Skip to content

A Multi-center Randomized Controlled Study of the Effects of a Camp-Based Lifestyle Intervention on a Population of Blood Pressure 130 to 139 and/or 80 to 89 mmHg

A Multi-center Randomized Controlled Study of the Effects of a Camp-Based Lifestyle Intervention on a Population of Blood Pressure 130~139 and/or 80~89 mmHg

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079399
Enrollment
Unknown
Registered
2024-01-02
Start date
2024-01-15
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

C-LIFE group:"C-LIFE" lifestyle intervention

Sponsors

Tianjin Kanghui Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years (18 years = age < 65 years). 2. During the screening period, mean values of blood pressure at 2 visits examination room at different time points (not on the same day, less than 1 week apart) should be controlled: SBP < 140 mmHg and DBP < 90 mmHg; 130 mmHg = SBP = 139mmHg and/or 80 mmHg = DBP = 89 mmHg; 3. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Having taken anti-hypertensive drugs within two weeks prior to enrollment; 2. History of stroke (except for lacunar cerebral infarction and transient ischemic attack); 3. History of acute myocardial infarction or unstable angina; history of hemodialysis (PCI or CABG); 4. Severe hepatic or renal disease, hyperkalemia (ALT = 3 times the upper limit of normal; patients on dialysis therapy or estimated glomerular filtration rate[eGFR] <30 ml/min/1.73 m2; blood potassium =5.5 mmol/L); 5. Presence of persistent atrial fibrillation or cardiac arrhythmia interfering with electronic sphygmomanometer measurements; 6. Have other concomitant serious illnesses that may prevent their enrollment or affect their survival, such as malignant tumors or AIDS; 7.Those with cognitive impairment or those who are unable to take care of themselves; 8. Pregnancy or lactation, or planned pregnancy; 9.After organ transplantation; 10. Those who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Blood Pressure;Limb blood pressure/baPWV;Blood biochemistry;

Secondary

MeasureTime frame
ECG;Cardiological ultrasound;Carotid ultrasound ;Weight;Waist;

Countries

China

Contacts

Public ContactLI YUMING

Tianjin Kanghui Hospital

cardiolab@live.com+86 22 5868 0999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026